This content is machine translated Cardio-renal syndrome Iron substitution: when, how and for how long? Iron deficiency in cardio-renal patients is not a trivial matter. Chronic heart failure, for example, is not only a common condition but also often associated with iron deficiency. This in…
View Post 7 min This content is machine translated Non-infectious complications after HSCT Cure for multiple sclerosis at any price? Hematopoietic stem cell transplantation (HSCT) is used as ultima ratio in multiple sclerosis. The reboot of the immune system is aimed at healing, but carries strong side effects. Both infectious…
View Post 5 min This content is machine translated Relapsed/refractory multiple myeloma The BCMA molecule as a beacon of hope The prognosis in relapsed and refractory multiple myeloma (RRMM) remains grim. Now, at the annual meeting of the American Society of Hematology (ASH), data have been presented that raise faint…
View Post 7 min This content is machine translated Non-infectious complications after HSCT Lungs at high risk! Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignant and non-malignant diseases. However, both infectious and noninfectious pulmonary complications can lead to increased morbidity and…
View Post 10 min This content is machine translated Non-chemotherapy-induced neutropenia Isolated neutropenia: a clinical picture with many faces Neutropenia is a frequent guest in the practice as an independent clinical picture, but also as an accompanying symptom of many diseases and as an adverse drug reaction. The accompanying… CME-Test
View Post 5 min This content is machine translated Myelofibrosis Treatment in transition With the introduction of the Janus kinase (JAK) inhibitor ruxolitinib, therapy for myelofibrosis has changed dramatically in recent years. Nevertheless, further innovation is needed, especially in the second line. Promising…
View Post 4 min This content is machine translated Prognosis of chronic lymphocytic leukemia Coffee grounds and crystal ball of science Valid prognostic and especially predictive markers can play a crucial role in the treatment of cancer. With the development of new therapeutic options for the treatment of chronic lymphocytic leukemia…
View Post 2 min This content is machine translated Iron deficiency Modern treatment management in the lifespan Iron deficiency is a common problem in family practice and can occur throughout a person’s lifespan. The reasons are varied, as are the symptoms that a deficient iron level can…
View Post 6 min This content is machine translated CAR-T Cells Own immune cell as therapy With the rapid development of new therapeutic options in oncology, immunotherapy has a high priority. Thus, CAR T cells are also a promising approach to treat advanced cancers. In particular,…
View Post 11 min This content is machine translated Sideropenia Iron deficiency in the oncological patient Worldwide, iron deficiency is the most common deficiency disease. In Europe, the prevalence is 5-10% and is one of the most common causes of anemia, accounting for about 50%. An…
View Post 2 min This content is machine translated Paroxymal Nocturnal Hemoglobinuria (PNH) Ravulizumab now reimbursable The first approved long-acting complement inhibitor for patients with PNH, ravulizumab, has been approved for nationwide reimbursement by the federal health department. This gives adult PNH patients in Switzerland access…
